10:21 AM EST - Crescita Therapeutics Inc. : Has signed an exclusive commercialization and supply agreement with Egis Pharmaceuticals PLC, a leading generic pharmaceutical company in Central Eastern Europe for the rights to Pliaglisin eight countries comprising: Hungary, Bulgaria, Czech Republic, Slovakia, Poland, Russia, Latvia and Lithuania. Crescita Therapeutics Inc.
shares T.CTX are trading unchanged at $0.58.
